BioSpace News Archive

Medvantx, Inc., the leading provider of ecommerce enabled pharmacy solutions, is pleased to announce the addition of Slater Nash, as Chief Pharmacy Officer.

Milestone Pharmaceuticals Inc. announced that the underwriters for its initial public offering of common shares have fully exercised their option to purchase an additional 825,000 common shares at the public offering price of $15.00 per share.

Nxt-ID, Inc., a provider of healthcare devices as well as payment, credential management, and authentication platform services, announces its next upcoming investor webcast.

AVITA Medica announced that Dale A. Sander is resigning as Chief Financial Officer (CFO) to spend more time with his family on the east coast, effective immediately.

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) announced that the US Food and Drug Administration (FDA) has approved BAVENCIO® (avelumab) in combination with INLYTA® (axitinib) for the first-line treatment of patients with advanced renal cell carcinoma (RCC).

Crucial Data Solutions announces the availability of private cloud storage for clinical trials conducted on Clinical Studio©, its signature electronic data capture (EDC) and trial management (CTMS) system

Myovant Sciences (NYSE: MYOV), a clinical-stage healthcare company focused on developing and commercializing innovative therapies for women’s health and prostate cancer, today announced that LIBERTY 1, the first of two Phase 3 studies of once daily relugolix combination therapy met its primary efficacy endpoint and six key secondary endpoints in women with uterine fibroids.

ValGenesis will continue to strengthen its presence in this region to better serve customer expectations of best-in-class digital validation lifecycle solutions and delivery.

James Wiskin, Ph.D, QT Ultrasound’s Principal Scientist, invited to lecture on innovative technology

Panel discussion will explore advanced approaches to gathering and analyzing real-world data and real-world evidence that can enable clinical assertions to support regulatory and reimbursement objectives